These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
533 related items for PubMed ID: 20308465
1. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation. Bargellini I, Vignali C, Cioni R, Petruzzi P, Cicorelli A, Campani D, De Simone P, Filipponi F, Bartolozzi C. Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465 [Abstract] [Full Text] [Related]
10. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program. Nemes B, Gelley F, Piros L, Zádori G, Görög D, Fehérvári I, Kóbori L, Sárváry E, Nagy P, Kiss A, Doros A. Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108 [Abstract] [Full Text] [Related]
11. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma. Otto G, Heise M, Moench C, Herber S, Bittinger F, Schuchmann M, Hoppe-Lotichius M, Pitton M. Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776 [Abstract] [Full Text] [Related]
12. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization. Kim HD, Shim JH, Kim GA, Shin YM, Yu E, Lee SG, Lee D, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS. J Hepatol; 2015 May; 62(5):1076-84. PubMed ID: 25529626 [Abstract] [Full Text] [Related]
14. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Kim JH, Yoon HK, Ko GY, Gwon DI, Jang CS, Song HY, Shin JH, Sung KB. Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463 [Abstract] [Full Text] [Related]
15. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization. Gabr A, Abouchaleh N, Ali R, Vouche M, Atassi R, Memon K, Asadi AA, Baker T, Caicedo JC, Desai K, Fryer J, Hickey R, Abeccassis M, Habib A, Hohlastos E, Ganger D, Kulik L, Lewandowski RJ, Riaz A, Salem R. Eur J Radiol; 2017 Aug; 93():100-106. PubMed ID: 28668402 [Abstract] [Full Text] [Related]
18. Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis. Moschouris H, Malagari K, Papadaki MG, Kornezos I, Matsaidonis D. Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1022-7. PubMed ID: 20101403 [Abstract] [Full Text] [Related]
19. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. Kim DY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Shin SW, Choo SW, Do YS, Rhee JC. World J Gastroenterol; 2006 Nov 21; 12(43):6992-7. PubMed ID: 17109521 [Abstract] [Full Text] [Related]